Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 2/20 | 0.61 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.60 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.60 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.60 |
| ▸ | HTT | P42858 | 2/20 | 0.60 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.60 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | GLA | P06280 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | NPY1R | P25929 | 1/20 | 0.60 |
| ▸ | NPY2R | P49146 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL451885 | 1.00 | ADORA2A (0.61) | ADORA2AADORA2BTSHRLMNAPMP22 | |
| SCHEMBL451884 | 1.00 | ADORA2A (0.61) | ADORA2AADORA2BTSHRLMNAPMP22 | |
| SCHEMBL28758971 | 0.92 | ADORA2A (0.65) | ADORA2AADORA2BTSHRLMNAPMP22 | |
| SCHEMBL30208555 | 0.88 | ADORA2A (0.60) | ADORA2AADORA2BTSHRLMNAPMP22 | |
| SCHEMBL28409183 | 0.87 | SLC29A1 (0.67) | ADORA2AADORA2BSLC29A1 | |
| SCHEMBL15865951 | 0.86 | BMPR1B (0.68) | ADORA2AADORA2BSLC29A1 | |
| SCHEMBL3022531 | 0.86 | BMPR1B (0.68) | ADORA2AADORA2BSLC29A1 | |
| SCHEMBL28477260 | 0.86 | ADORA2A (0.67) | ADORA2AADORA2BTSHRLMNAPMP22 | |
| SCHEMBL24920112 | 0.86 | ADORA2A (0.67) | ADORA2AADORA2BTSHRLMNAPMP22 | |
| SCHEMBL30208521 | 0.86 | ADORA2A (0.67) | ADORA2AADORA2BTSHRLMNAPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2025151711-A1 | NUCLEIC ACID VACCINES TARGETING METHANOGENS | Arkea Bio Corp. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025137275-A1 | NOVEL CAS NUCLEASES AND POLYNUCLEOTIDES ENCODING THE SAME | MODERNATX, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| WO-2025122721-A1 | CHIMERIC PROTEINS AND USES THEREOF | SHATTUCK LABS, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| WO-2025049610-A1 | MULTI-ACTION PEPTIDES | SHATTUCK LABS, INC. (US) | 2025-03-06 | — | — | WO | claimed |
| EP-4008334-B1 | MANNOSE-BASED MRNA TARGETED DELIVERY SYSTEM AND USE THEREOF | SHENZHEN RHEGEN BIOTECHNOLOGY CO LTD (CN) | 2024-12-04 | — | — | EP | claimed |
| WO-2024233308-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. (US) | 2024-11-14 | — | — | WO | claimed |
| EP-4426725-A2 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | Shattuck Labs, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| EP-4426720-A1 | MODIFIED MRNA THERAPEUTICS | Shattuck Labs, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| EP-4305051-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | Shattuck Labs, Inc. (US) | 2024-01-17 | — | — | EP | claimed |
| WO-2023077156-A1 | MODIFIED MRNA THERAPEUTICS | SHATTUCK LABS, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| WO-2023077152-A2 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| WO-2023023055-A1 | COMPOSITIONS AND METHODS FOR OPTIMIZING TROPISM OF DELIVERY SYSTEMS FOR RNA | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2023-02-23 | — | — | WO | claimed |
| WO-2022192236-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | SHATTUCK LABS, INC. (US) | 2022-09-15 | — | — | WO | claimed |
| EP-4747380-A1 | MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE | CRISPR Therapeutics AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| CN-122070366-A | Cyclic RNA compositions and methods | 欧纳医疗公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2026102034-A1 | COMPOSITIONS AND METHODS FOR GENETIC AND EPIGENETIC MODULATION | JUNIPERO THERAPEUTICS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-3958893-A1 | MRNA FORMULATION | eTheRNA Immunotherapies NV (BE) | 2022-03-02 | — | — | EP | disclosed |
| WO-2022040224-A1 | COMPOSITIONS COMPRISING A NUCLEASE AND USES THEREOF | Arbor Biotechnologies, Inc. (US) | 2022-02-24 | — | — | WO | disclosed |
| WO-2022032154-A2 | COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM | MODERNATX, INC. (US) | 2022-02-10 | — | — | WO | disclosed |